- Oral presentation
- Open access
- Published:
Non-neutralizing antibodies and vaccine-induced protection
Retrovirology volume 3, Article number: S26 (2006)
Neutralizing antibody is critical for sterilizing immunity, but recent data suggest binding antibodies may contribute to protection. A replicating Ad-HIVenv prime/Env protein boost regimen induced potent antibodies with broad antibody-dependent cellular cytotoxic activity (ADCC) across HIV clades. A multigenic Ad-SIV prime/Env subunit boost regimen elicited strong protection in rhesus macaques against SIVmac251. Significant reduction in acute viremia was correlated with non-neutralizing, ADCC-mediating anti-Env antibodies. Further, compared to multigenic vaccines, an Ad-HIVtat+Ad-HIVenv prime/Tat and Env protein boost regimen elicited significantly enhanced protection against SHIV89.6P associated with Tat and Env binding antibodies. Passive transfer of ADCC-mediating IgG has not protected neonatal macaques against oral SIV challenge. But a high challenge dose, limited IgG, and poorly functional or insufficient neonatal NK effector cells may have precluded protection. In future, other challenge routes will be studied in juvenile macaques using more ADCC-mediating IgG.
Author information
Authors and Affiliations
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Demberg, T., Florese, R.H., Gomez-Roman, V.R. et al. Non-neutralizing antibodies and vaccine-induced protection. Retrovirology 3 (Suppl 1), S26 (2006). https://doi.org/10.1186/1742-4690-3-S1-S26
Published:
DOI: https://doi.org/10.1186/1742-4690-3-S1-S26